Table 7.
Effect of methionine and vitamin B‐complex on hematological parameters at 6 months of antituberculosis treatment
| Control | Test | P‐value | |
|---|---|---|---|
| ESR (mm/h) | 23 (IQR: 19.00–29.00) | 32 (IQR: 23.00–41.50) | 0.622 |
| WBC (x109/L) | 4.05 (IQR: 3.55–5.20) | 3.92 (IQR: 2.76–5.30) | 0.259 |
| RBC (x1012/L) | 4.39 (IQR: 4.01–4.83) | 4.34 (IQR: 4.08–4.82) | 0.045a |
| HGB (g/dL) | 12.4 (IQR: 10.83–14.15) | 12.9 (IQR: 11.90–14.60) | 0.798 |
| PCV (x103 μL) | 37.85 (IQR: 35.43–45.40) | 38.4 (IQR: 35.00–42.20) | 0.037a |
| PLT (x103/L) | 265 (IQR: 180.25–329.75) | 228 (IQR: 190.00–304.00) | 0.320 |
| NEUT (×109/L) | 1.64 (IQR: 1.06–2.54) | 2.29 (IQR: 1.69–4.00) | <0.001a |
| NEUT (%) | 46.6 (IQR: 36.90–52.70) | 55.15 (IQR: 47.08–67.23) | 0.032a |
| LYMPH (%) | 43.4 (IQR: 26.20–52.20) | 30.65 (IQR: 23.25–42.40) | 0.008a |
| LYMPH (×109/L) | 1.9 (IQR: 1.36–2.90) | 1.32 (IQR: 0.98–2.00) | 0.624 |
| MCV (fL) | 84.7 (IQR: 78.80–93.60) | 88.2 (IQR: 81.25–91.30) | 0.140 |
| MCH (pg) | 29 (IQR: 26.80–30.80) | 27.9 (IQR: 25.75–29.80) | 0.698 |
| MCHC (g/dL) | 33.2 (IQR: 31.50–34.60) | 31.95 (IQR: 31.00–33.6) | 0.012a |
a
Mann Whitney U test (significant); IQR, Interquartile range.